• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者的平均血小板体积。

Mean platelet volume in patients with non-alcoholic fatty liver disease.

机构信息

Düzce Medical School Department of Cardiology, Duzce University, 81620 Konuralp, Düzce, Turkey.

出版信息

Platelets. 2010;21(1):29-32. doi: 10.3109/09537100903391023.

DOI:10.3109/09537100903391023
PMID:19947902
Abstract

Mean platelet volume (MPV) is an indicator of platelet activation. Platelet activation and aggregation are central processes in the pathophysiology of coronary heart disease. Non-alcoholic fatty liver disease (NAFLD) is present up to one-third of the general population and the majority of patients with cardio-metabolic risk factors such as abdominal obesity, type 2 diabetes and other components of the metabolic syndrome (MS). The aim of the current study was to investigate the MPV in patients who had NAFLD. MPV values of the patients with NAFLD and of the patients without fatty liver disease were compared. NAFLD patients had significantly higher body mass index compared to the control cases. Among biochemical variables, fasting plasma glucose and triglyceride were significantly higher in the NAFLD group. NAFLD cases also had lower platelet count and higher MPV (10.43 +/- 1.14 vs. 9.09 +/- 1.25; p < 0.001, respectively). MPV was positively correlated with AST (r: 0.186, p < 0.042), ALT level (r: 0.279; p 0.002) and the presence of NAFLD (0.492; p < 0.001) but negatively correlated with platelet number (r: -0.26; p 0.004) and creatinine (r: -0.255; p 0.005). In logistic regression analysis (age, gender, NAFLD, body mass index, high-density lipid (HDL) cholesterol, systolic and diastolic blood pressure, triglyceride and fasting plasma glucose were used as covariates) only NAFLD was found to be the independent predictor of MPV (Odds Ratio (OR) 21.98) [95% confidence interval (CI): 2.404-201.048; p: 0.006]. We have shown for the first time in the literature that, patients with NAFLD have higher MPV. It may have prognostic value in NAFLD patients indicating a possible cardiovascular disease (CVD) risk increase.

摘要

平均血小板体积 (MPV) 是血小板活化的指标。血小板活化和聚集是冠心病病理生理学的核心过程。非酒精性脂肪性肝病 (NAFLD) 可在三分之一的普通人群中出现,并且大多数患有代谢危险因素的患者,如腹部肥胖、2 型糖尿病和代谢综合征 (MS) 的其他组成部分。本研究旨在探讨患有 NAFLD 的患者的 MPV 值。比较了 NAFLD 患者和无脂肪肝疾病患者的 MPV 值。与对照组相比,NAFLD 患者的体重指数明显更高。在生化变量中,空腹血糖和甘油三酯在 NAFLD 组中明显升高。NAFLD 患者的血小板计数也较低,MPV 较高(10.43 +/- 1.14 对 9.09 +/- 1.25;分别为 p < 0.001)。MPV 与 AST(r:0.186,p < 0.042)、ALT 水平(r:0.279;p < 0.002)和 NAFLD 的存在呈正相关(r:0.492;p < 0.001),但与血小板计数呈负相关(r:-0.26;p < 0.004)和肌酐(r:-0.255;p < 0.005)。在逻辑回归分析中(年龄、性别、NAFLD、体重指数、高密度脂蛋白 (HDL) 胆固醇、收缩压和舒张压、甘油三酯和空腹血糖作为协变量),只有 NAFLD 被发现是 MPV 的独立预测因子(优势比(OR)21.98)[95%置信区间(CI):2.404-201.048;p:0.006]。我们首次在文献中表明,患有 NAFLD 的患者 MPV 较高。它可能在 NAFLD 患者中具有预后价值,表明可能增加心血管疾病 (CVD) 风险。

相似文献

1
Mean platelet volume in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的平均血小板体积。
Platelets. 2010;21(1):29-32. doi: 10.3109/09537100903391023.
2
Lifestyle modification decreases the mean platelet volume in prehypertensive patients.生活方式的改变可降低高血压前期患者的平均血小板体积。
Platelets. 2009 Feb;20(1):58-63. doi: 10.1080/09537100802613449.
3
Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease.活检证实的非酒精性脂肪性肝病患者的平均血小板体积。
Platelets. 2013;24(3):194-9. doi: 10.3109/09537104.2012.688898. Epub 2012 May 30.
4
The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population.非酒精性肝脂肪变性与肥胖韩国人群中平均血小板体积的相关性。
Platelets. 2011;22(6):442-6. doi: 10.3109/09537104.2010.540049. Epub 2011 Jul 13.
5
Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes.老年人群平均血小板体积(MPV)的决定因素:体脂、血糖及缺血性心电图改变的相关性
Thromb Haemost. 2008 Jun;99(6):1079-84. doi: 10.1160/TH07-12-0712.
6
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.代谢风险因素患者的胆石症与非酒精性脂肪性肝病标志物
Scand J Gastroenterol. 2012 Feb;47(2):197-203. doi: 10.3109/00365521.2011.643481. Epub 2011 Dec 19.
7
Mean platelet volume in patients with prehypertension and hypertension.高血压前期和高血压患者的平均血小板体积。
Clin Hemorheol Microcirc. 2010;45(1):67-72. doi: 10.3233/CH-2010-1327.
8
Increased mean platelet volume is associated with arterial stiffness.血小板平均体积增大与动脉僵硬度相关。
Platelets. 2011;22(6):447-51. doi: 10.3109/09537104.2011.565431. Epub 2011 Apr 7.
9
Mean platelet volume in patients with subclinical hypothyroidism.亚临床甲状腺功能减退症患者的平均血小板体积。
Platelets. 2011;22(2):143-7. doi: 10.3109/09537104.2010.508130. Epub 2011 Jan 25.
10
Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的血尿素氮升高。
Hepatogastroenterology. 2013 Mar-Apr;60(122):343-5.

引用本文的文献

1
Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study.瘦型和非瘦型非酒精性脂肪性肝病的临床特征:一项横断面研究。
Nutr Metab (Lond). 2025 May 12;22(1):40. doi: 10.1186/s12986-025-00927-y.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients-The Relationship with Platelets Indicators.2型糖尿病患者中代谢功能障碍相关脂肪性肝病与血小板指标的关系
Medicina (Kaunas). 2024 Dec 21;60(12):2091. doi: 10.3390/medicina60122091.
3
The impact of a short-term high-fat diet on coagulation function in a mouse model and its role in exacerbating concanavalin A-induced liver injury.
短期高脂饮食对小鼠模型凝血功能的影响及其在加重伴刀豆球蛋白A诱导的肝损伤中的作用。
BMC Nutr. 2024 Dec 18;10(1):158. doi: 10.1186/s40795-024-00966-3.
4
Long-Term Oral Administration of Hyperimmune Egg-Based IgY-Rich Formulations Induces Mucosal Immune Response and Systemic Increases of Cytokines Involved in Th2- and Th17-Type Immune Responses in C57BL/6 Mice.长期口服高免鸡蛋源 IgY 制剂可诱导 C57BL/6 小鼠黏膜免疫应答和涉及 Th2 和 Th17 型免疫应答的细胞因子的全身增加。
Int J Mol Sci. 2024 Aug 9;25(16):8701. doi: 10.3390/ijms25168701.
5
Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.血小板、抗血小板治疗与代谢功能障碍相关脂肪性肝病:一篇叙述性综述
Life (Basel). 2024 Apr 4;14(4):473. doi: 10.3390/life14040473.
6
Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease.瘦型非酒精性脂肪性肝病的临床特征和蛋白质组学特征。
Front Endocrinol (Lausanne). 2023 Nov 16;14:1171397. doi: 10.3389/fendo.2023.1171397. eCollection 2023.
7
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.将非酒精性脂肪性肝病重新命名为代谢相关脂肪性肝病对其患病率、特征及危险因素的影响。
World J Hepatol. 2023 Aug 27;15(8):985-1000. doi: 10.4254/wjh.v15.i8.985.
8
Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.非肥胖人群中非酒精性脂肪性肝病的临床特征。
Obes Facts. 2023;16(5):427-434. doi: 10.1159/000530845. Epub 2023 May 22.
9
A non-invasive method for estimating the severity of liver steatosis and the risk of fibrosis in non-obese type 2 diabetes patients with NAFLD.一种用于评估非肥胖型2型糖尿病合并非酒精性脂肪性肝病患者肝脂肪变性严重程度及纤维化风险的非侵入性方法。
Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):480-487. doi: 10.4183/aeb.2022.480.
10
Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?平均血小板体积是简单的非酒精性脂肪肝标志物吗?
Indian J Gastroenterol. 2023 Apr;42(2):219-225. doi: 10.1007/s12664-022-01330-8. Epub 2023 Apr 27.